COST EFFECTIVENESS ANALYSIS OF THE USE OF DACLATASVIR plus ASUNAPREVIR IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C IN PERU

被引：0
|
作者：
Sanabria, C. [1 ]
Roman, R. [2 ]
Montano, D. [3 ]
Mercado, D. [3 ]
Valenzuela, G. [3 ]
Caporale, J. E. [4 ]
机构：
[1] Univ Nacl Mayor San Marcos, Lima, Peru
[2] EsSalud, Lima, Peru
[3] BMS, San Isidro, Peru
[4] BMS, Vicente Lopez, Argentina
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.2910
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN25
引用
收藏
页码：A930 / A930
页数：1
相关论文
共 50 条
  • [21] Estimating the cost-effectiveness of daclatasvir plus asunaprevir in difficult to treat Japanese patients chronically infected with hepatitis C genotype 1b
    McEwan, Phil
    Ward, Thomas
    Webster, Samantha
    Yuan, Yong
    Kalsekar, Anupama
    Kamae, Isao
    Kobayashi, Masahiro
    Tang, Ann
    Kumada, Hiromitsu
    HEPATOLOGY RESEARCH, 2016, 46 (05) : 423 - 433
  • [22] Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
    Suda, Goki
    Kudo, Mineo
    Nagasaka, Atsushi
    Furuya, Ken
    Yamamoto, Yoshiya
    Kobayashi, Tomoe
    Shinada, Keisuke
    Tateyama, Miki
    Konno, Jun
    Tsukuda, Yoko
    Yamasaki, Kazushi
    Kimura, Megumi
    Umemura, Machiko
    Izumi, Takaaki
    Tsunematsu, Seiji
    Sato, Fumiyuki
    Terashita, Katsumi
    Nakai, Masato
    Horimoto, Hiromasa
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    JOURNAL OF GASTROENTEROLOGY, 2016, 51 (07) : 733 - 740
  • [23] Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis
    Ismail, Waleed A.
    Yousef, Ayman E.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (08) : 1025 - 1029
  • [24] Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
    Goki Suda
    Mineo Kudo
    Atsushi Nagasaka
    Ken Furuya
    Yoshiya Yamamoto
    Tomoe Kobayashi
    Keisuke Shinada
    Miki Tateyama
    Jun Konno
    Yoko Tsukuda
    Kazushi Yamasaki
    Megumi Kimura
    Machiko Umemura
    Takaaki Izumi
    Seiji Tsunematsu
    Fumiyuki Sato
    Katsumi Terashita
    Masato Nakai
    Hiromasa Horimoto
    Takuya Sho
    Mitsuteru Natsuizaka
    Kenichi Morikawa
    Koji Ogawa
    Naoya Sakamoto
    Journal of Gastroenterology, 2016, 51 : 733 - 740
  • [25] Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis
    Fujii, Hideki
    Kimura, Hiroyuki
    Kurosaki, Masayuki
    Hasebe, Chitomi
    Akahane, Takehiro
    Yagisawa, Hitoshi
    Kato, Keizo
    Yoshida, Hideo
    Itakura, Jun
    Sakita, Shinya
    Satou, Takashi
    Okada, Kazuhiko
    Kusakabe, Atsunori
    Kojima, Yuji
    Kondo, Masahiko
    Morita, Atsuhiro
    Nasu, Akihiro
    Tamada, Takashi
    Okushin, Hiroaki
    Kobashi, Haruhiko
    Tsuji, Keiji
    Joko, Kouji
    Ogawa, Chikara
    Uchida, Yasushi
    Mitsuda, Akeri
    Sohda, Tetsuro
    Ide, Yasushi
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2018, 48 (09) : 746 - 756
  • [26] Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C
    Reona Morio
    Michio Imamura
    Yoshiiku Kawakami
    Kei Morio
    Tomoki Kobayashi
    Satoe Yokoyama
    Yuki Kimura
    Yuko Nagaoki
    Tomokazu Kawaoka
    Masataka Tsuge
    Akira Hiramatsu
    C. Nelson Hayes
    Hiroshi Aikata
    Shoichi Takahashi
    Daiki Miki
    Hidenori Ochi
    Nami Mori
    Shintaro Takaki
    Keiji Tsuji
    Kazuaki Chayama
    Journal of Gastroenterology, 2017, 52 : 504 - 511
  • [27] Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C
    Morio, Reona
    Imamura, Michio
    Kawakami, Yoshiiku
    Morio, Kei
    Kobayashi, Tomoki
    Yokoyama, Satoe
    Kimura, Yuki
    Nagaoki, Yuko
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Hayes, C. Nelson
    Aikata, Hiroshi
    Takahashi, Shoichi
    Miki, Daiki
    Ochi, Hidenori
    Mori, Nami
    Takaki, Shintaro
    Tsuji, Keiji
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (04) : 504 - 511
  • [28] Efficacy and safety of a fixed dose combination tablet of asunaprevir plus beclabuvir plus daclatasvir for the treatment of Hepatitis C
    Zappulo, Emanuela
    Scotto, Riccardo
    Buonomo, Antonio Riccardo
    Maraolo, Alberto Enrico
    Pinchera, Biagio
    Gentile, Ivan
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (03) : 261 - 273
  • [29] Integrated pharmacokinetic/viral dynamic model for daclatasvir/asunaprevir in treatment of patients with genotype 1 chronic hepatitis C
    Wang, He-chuan
    Ren, Yu-peng
    Qiu, Yue
    Zheng, Jenny
    Li, Gai-ling
    Hu, Chuan-pu
    Zhou, Tian-yan
    Lu, Wei
    Li, Liang
    ACTA PHARMACOLOGICA SINICA, 2018, 39 (01) : 140 - 153
  • [30] Daclatasvir plus asunaprevir in treatment-naive patients with hepatitis C virus genotype 1b infection
    Wei, Lai
    Wang, Fu-Sheng
    Zhang, Ming-Xiang
    Jia, Ji-Dong
    Yakovlev, Alexey A.
    Xie, Wen
    Burnevich, Eduard
    Niu, Jun-Qi
    Jung, Yong Jin
    Jiang, Xiang-Jun
    Xu, Min
    Chen, Xin-Yue
    Xie, Qing
    Li, Jun
    Hou, Jin-Lin
    Tang, Hong
    Dou, Xiao-Guang
    Gandhi, Yash
    Hu, Wen-Hua
    McPhee, Fiona
    Noviello, Stephanie
    Treitel, Michelle
    Mo, Ling
    Deng, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (12) : 1361 - 1372
12345